Iwasaki Koji (岩崎高治), president of Life Corporation, said at an earnings briefing on 8 October that he expected synergies from integrating procurement and marketing through the acquisition of ALBIS Co.,Ltd. The tender offer is scheduled to run through 10 November, while investment for the fiscal year ending February 2027 is expected to total approximately ¥48.8 billion.
At an earnings briefing, Iwasaki Koji (岩崎高治), president of Life Corporation, discussed ALBIS Co.,Ltd., which is currently subject to a tender offer, and indicated an intention to build a mutually beneficial relationship by maintaining customer relationships and local food culture while strengthening purchasing power through the centralisation of food and material procurement, consolidating seafood sourcing and sharing Life's marketing expertise.
Regarding store openings in the Chukyo region, Iwasaki indicated that ALBIS Co.,Ltd. had opened 4 stores and suggested that the company aimed to expand nationwide under the ALBIS Co.,Ltd. or Bio-Ral name rather than the Life name.
Investment associated with this M&A is expected to total ¥48.8 billion in the fiscal year ending February 2027, making it the largest scale in the past 10 years. The tender offer for ALBIS Co.,Ltd. is scheduled to run through 10 November. This M&A is not included in the earnings forecast.